Ebstein's anomaly of the tricuspid valve prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
{{Template:ebstein's anomaly of the tricuspid valve}} | |||
{{CMG}} and Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu] | {{CMG}} and Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu] | ||
__NOTOC__ | __NOTOC__ | ||
| Line 17: | Line 18: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
{{Congenital malformations and deformations of circulatory system}} | {{Congenital malformations and deformations of circulatory system}} | ||
[[Category:DiseaseState]] | [[Category:DiseaseState]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Pediatrics]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 18:46, 27 June 2011
|
Ebsteins anomaly of the tricuspid valve Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Ebstein's anomaly of the tricuspid valve prognosis On the Web | |
|
American Roentgen Ray Society Images of Ebstein's anomaly of the tricuspid valve prognosis | |
|
Ebstein's anomaly of the tricuspid valve prognosis in the news | |
|
Risk calculators and risk factors for Ebstein's anomaly of the tricuspid valve prognosis | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]
Adverse prognostic factors are
a) NYHA Class III or IV
b) Moderate to severe cardiomegaly
c) Cyanosis or an O2 sat < 90%
d) Disability during infancy
e)Paradoxical emboli
References